Source: Eur Respir J 2013; 42: 1055-1063
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Koutsourelakis Ioannis, Minaritzoglou Aliki, Zakynthinos Georgios, Vagiakis Emmanouil, Zakynthinos Spyros. The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients. Eur Respir J 2013; 42: 1055-1063

Member's Comments

No comment yet.

Related content which might interest you: Patients with obstructive sleep apnoea free of nasal obstruction have increased oral breathing Source: Annual Congress 2007 - Pathogenesis of obstructive sleep apnoea Year: 2007 The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006 Nasal surgery improves obstructive sleep apnoea in patients with decreased nasal breathing Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Obstructive sleep apnoea and oral breathing in patients free of nasal obstruction Source: Eur Respir J 2006; 28: 1222-1228 Year: 2006 Effect of treating severe nasal obstruction on the severity of obstructive sleep apnoea Source: Eur Respir J 2005; 25: 521-527 Year: 2005 Effect of upper-airway stimulation for obstructive sleep apnoea on airway dimensions Source: Eur Respir J 2015; 45: 129-138 Year: 2015 Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Sleep and Breathing Conference 2021 Year: 2021 Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Postural effects on nasal resistance in obstructive sleep apnoea (OSA) and efficacy of a novel oral appliance Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018 Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Effect of obstructive sleep apnea on asthma control Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring Source: Eur Respir J 2007; 30: 1208-1215 Year: 2007 Influence of electrostimulation of pharyngeal and laryngeal muscles with application of prolonged beta-2 agonist on functional signs of obstructive sleep apnea syndrome in patients with obstructive sleep apnea syndrome combined with chronic obstructive Source: Eur Respir J 2003; 22: Suppl. 45, 467s Year: 2003 Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP. Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021 Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP. Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002